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Progress in the 
Development of Aqueous 
Two-Phase Systems 
Comprising Ionic Liquids 
for the Downstream 
Processing of Protein-
Based Biopharmaceuticals
The advent of biopharmaceuticals in modern medicine has brought 
enormous benefi ts to treat chronic and life-threatening diseases 
while improving the well-being of humans. Proteins (including 
antibodies) represent a large fraction of the biopharmaceuticals 
market, but are still amongst the costliest options due to the lack of 
cost-eff ective purifi cation techniques. The most relevant strategies 
in the downstream processing of protein-based biopharmaceuticals 
are the highly selective nature of chromatographic techniques, which 
however, present some drawbacks including the diffi  culty to apply in 
large scale due to batch processing, large scale pressure drops,1 low 
chemical and proteolytic stability, and high cost.2 To overcome such 
limitations, alternative downstream processes have been proposed, 
such as aqueous two-phase systems (ATPS). These systems were 
initially proposed by Albertsson in the mid 1950s as an alternative 
to traditional liquid-liquid extraction techniques,3 consisting of 
two immiscible aqueous-rich phases that separate above given 
concentrations, being one aqueous phase enriched in one of the 
solutes while in the other phase the second component prevails.4 An 
overview of the application of ATPS for the purifi cation of proteins is 
represented in Figure 1, being additionally illustrated a typical ATPS 
ternary phase diagram in an orthogonal representation, in which the 
water concentration is not shown (pure water becomes the origin of 
the orthogonal axes, corresponding to the amount required to reach 
100 wt% in a given mixture composition).4
In comparison with other extraction techniques, ATPS display several 
advantages, spanning from their environmentally friendly and 
biocompatible character, low cost, continuous operation and easiness 
Figure 1. Schematic representation of protein puri cation using 
an ATPS and of an orthogonal ternary phase diagram for a 
hypothetical system.
Pedro_SeptOct2019.indd   1 9/19/19   10:54 AM
in scaling-up. Moreover, being mainly composed of water, ATPS provide 
a gentle environment for the separation or downstream processing of 
proteins.1,5 Based on the exposed, ATPS have become a widely studied 
technology for their ability to separate and purify a wide range of 
biomolecules, including nucleic acids, proteins, antibodies and cells.
Polymers and salts were initially investigated as the main phase-
forming components of ATPS. More recently, following the pioneering 
work by Rogers and co-workers in 2003 on the possible creation of 
ATPS by the addition of aqueous solutions of ionic liquids (ILs) to 
inorganic salts,6 the extractive performance of ATPS comprising ILs 
has been deeply investigated. ILs are liquid molten salts typically 
composed of large and unsymmetrical organic cations and organic or 
inorganic anions, which generally present high thermal and chemical 
stabilities, and are non-fl ammable and non-volatile at ambient 
conditions. Furthermore, their aqueous solutions display an improved 
and unique solvation performance, thereby allowing enhanced 
extractions. An additional remarkable feature of ILs is their tunable 
character, which due to the large number of ion combinations allows 
researchers to adjust their physico-chemical properties to meet the 
requirements of specifi c applications.5 Indeed, in IL-ATPS there is the 
ability to tailor the phases’ polarities by a proper manipulation of the IL 
cation/anion design, allowing to overcome the limited polarity range 
of polymer-based ATPS.4 On their way as agents for the purifi cation of 
proteins, ILs have travelled a long path with major achievements in the 
21th century (Figure 2). Despite not being recent compounds – the 
synthesis of the fi rst IL was reported more than a century ago by Paul 
Walden -, the fi rst work involving the formation of IL-ATPS was reported 
in 2003, which were later (2007) applied for the fi rst time to extract 
proteins from urine by Wang and co-workers.7 Also in 2007, the fi rst 
evidence pointing out to the possible creation of ATPS involving ILs 
and polymers were documented by Rebelo and co-workers.8 Research 
on IL-ATPS has been driven in the last decade towards the use of ILs as 
feasible alternatives to polymer- and salt-rich phases in ATPS,4 namely 
in terms of: 1) characterizing the eff ect of ILs in biomolecules;9,10 2) 
synthesis of ILs of a more biodegradable and biocompatible nature;11
and 3) improving the recyclability of ILs.12
Proteins Stability in the IL Milieu
The application of ILs as solvent stabilizing media for proteins has 
been a hot topic of research. Up to date, most studies in the literature 
point out the importance of understanding the IL-protein interactions 
for any protein-related application. Moreover, it became clear the 
diffi  culty in devising general rules for protein stability in ILs due to 
the odd eff ects that distinct proteins suff er in the presence of ILs in 
which both the cation and anion properties as well as the lypophilic-
hydrophylic nature of the IL are changed.5 Albeit diff erent perspectives 
have been reported, exceptionally high catalytic activities in the 
presence of ILs were obtained, as exemplifi ed by the cytochrome c 
which displays an increased catalytic activity of more than 50-fold (in 
comparison with standard phosphate buff er solutions) when in the 
presence of aqueous solutions of cholinium glutarate (IL:H2O, 1:1).
13 An 
overview of the impact of ILs in the stability of a wide range of proteins, 
including laccase, lysozyme, cytochrome c, alcohol dehydrogenases 
(among many others) were recently reported by Kumar et al (2017)9 
and Schindl et al (2019).10 Overall, high stability and enzyme activity 
can be achieved by the proper selection of the IL chemical structure 
and its concentration.
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Figure 2. Milestones in the ILs scienti c arena towards their application in the puri cation of proteins and challenges to address 
in the future.
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Purifi cation of Proteins Using ATPS 
Comprising ILs
Representative works of ATPS comprising ILs for the extraction of 
proteins are shown in Table 1, namely with ILs as ATPS phase-forming 
components with salts14,15 or polymers,16,17 as adjuvants18 in polymer-
salt systems or as co-surfactants19 in aqueous micellar two-phase 
systems (AMTPS).
Gutiérrez-Arnillas et al14 proposed an integrated strategy for the 
recovery of a lipolytic enzyme, belonging to the class of lipases (EC 
3.1.1.2) which have attracted much interest and with widespread use 
in several industry sectors including food, drugs, fuels and detergents. 
The overall process includes the solubilization of Thermus thermophilus
HB27 biomass by imidazolium-based ILs and the addition of an 
inorganic salt, aiming the formation of an ATPS and further extraction. 
Among the ILs tested, the IL containing the longer alkyl side chain 
length – [C10mim]Cl, 1-decyl-3-methylimidazolium chloride – entailed 
a greater solubilization of cell biomass since it interacts with the 
negatively charged head of the Thermus membrane displacing 
cations, while the alkyl chain inserts into the membrane and forms 
channels. As a result, the majority of the enzyme activity was found in 
the extracellular fraction. Then, the IL was salted-out by the addition 
of an inorganic salt [(NH4)2SO4], being the majority (96%) of the target 
enzyme recovered in the top phase, i.e. the IL-rich phase.14
Dreyer and Kragl15 evaluated the possibility of combining an 
extraction process based on ATPS with the advantageous properties 
displayed by ILs, namely their ability to improve the catalytic activity 
of two alcohol dehydrogenases. To this end, ILs composed by acyclic 
ammonium salts containing cations with oligoethyleneglycol units - 
Ammoeng110™ and potassium phosphate salt (K2HPO4/KH2PO4 at a 
ratio of 1.82:1.00, pH7) were used for the formation of ATPS at 4 °C, 
envisaging the purifi cation of two alcohol dehydrogenases (ADH) from 
Lactobacillus brevis (ADH LB) and a thermophilic bacterium (ADH TB), 
which were independently expressed in E. coli. By proper tailoring the 
concentrations of IL and inorganic salt resorting experimental design 
and using the specifi c activity (U µg-1 protein) as the target parameter, 
both enzymes were succesfully extracted towards the IL-containing 
upper phase with 11.3% (w/w) IL and 19.2 % (w/w) salt for ADH LB and 
10.6% (w/w) IL and 19.6% (w/w) salt for ADH TB. In general, an increase 
of the specifi c activity of both enzymes was obtained in the IL-rich 
phase, indicating that they are recovered in a more purifi ed form. 
Additional advantages of using Ammoeng110™ include the enhanced 
stability displayed by the target enzymes, as shown by the increase of 
the half-life of ADH LB at 30 °C from 0.6 to 5.9 days in the presence of 
diff erent concentrations of IL ranging from 0 to 30 % (w/w), and also a 
favorable increase in the solubility of hydrophobic substrates such as 
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Table 1. Representative works addressing the puri cation of proteins (including antibodies) using ATPS comprising ILs.
Product Role of IL ILS Tested ATPS Composition Highlights Ref.
Lypolytic enzyme 
(Thermus thermophilus 
HB27)
Phase-forming 
component
[C2mim][C2SO4], [C2mim]
[(C2H5)2PO4], [C2mim]
[HSO4], [C2mim]Cl, 
[C6mim]Cl and [C10mim]Cl
16.4% (NH4)2SO4 + 37.7% 
[C10mim]Cl
Due to the higher hydrophobicity - higher alkyl chain length -, the addition 
of [C10mim]Cl to the culture medium permitted a change in the membrane 
permeability of the host, allowing to recover a major fraction of the enzyme in the 
extracellular medium. The addition of a salt allowed the formation of an ATPS and an 
extraction effi  ciency of the enzyme in the upper phase (IL-rich phase) of 96%.
[14]
ADH (Lactobacillus brevis 
(LB) and ADH from a 
thermophilic bacterium 
(TB))
Phase-forming 
component
Ammoeng110™
11.3 and 10.6% 
Ammoeng110™ + 
19.2% and 19.6% 
K2HPO4-KH2PO4 (pH7), 
respectively for ADH LB 
and ADH TB
Both enzymes were preferentially partitioned to the IL-containing upper phase 
with increasing in specifi c activities from 100% to 206.7 ± 5.3% and 403.4 ± 5.4%, 
respectively for LB ADH and TB ADH. Additional advantages of IL include their ability 
to: 1) enhance the solubility of hydrophobic substrates such as acetophenone, the 
substrate of ADH; 2) enhance the enzymatic activity of both enzymes, in which 
the half-life of LB ADH at 30 °C was increased from 0.6 to 5.9 days by varying the 
concentration of IL from 0 to 30% (w/w). 
[15]
IgG (Rabbit serum)
Phase-forming 
component
[Ch]+ combined with 
plant natural acids (IA, 
Abt, Gly, Pyr, C3C, Asc, 
Gen, Qui, D-Gal)
30% PPG 400 + 25% IL
Unlike ATPS based on conventional Ch-based ILs such as [Ch]Cl, [Ch][Lac] and [Ch][Ac] 
where IgG precipitation is observed, systems based on [Ch][Gly], [Ch][Pyr], [Ch][Asc], 
[Ch][D-Gal] allow the complete extraction and complete recovery of IgG. With exception 
of [Ch][IA], IgG is generally stable in the presence of the ILs herein reported.
[16] 
IgY (WSpF from Egg yolk)
Phase-forming 
component
[Ch]+ combined with 
[MES]-, [TES]-, [Tricine]-, 
[CHES]-, [HEPES]-
50% PPG 400 + 7-10% IL
(Physiological pH, 6-8)
ILs display self-buff ering characteristics within physiological pH region (6-8). Eco-
toxicity determination towards Vibrio fi scheri revealed the non-toxic character of the 
synthesized ILs. ATPS constituted by [Ch][Tricine] and [Ch][HEPES] yielded the highest 
extraction effi  ciencies (> 90%) in a single-step.
[17]
L-asparaginase
(Escherichia coli BL21 
(DE3))
Adjuvant
[C4mim]
+ combined with 
Cl-, [DMP]-, [CH3SO3]
-, 
[CF3SO3]
-
15% PEG 6000 + 15% 
Citrate buff er (pH7) + 
5% IL
Imidazolium-based ILs preferentially migrate to the PEG-rich phase. [C4mim][CH3SO3] 
and [C4mim][CF3SO3] (with less polar anions) enhance the hydrophobicity of the 
PEG-rich phase, decreasing the amount of contaminant proteins and increasing the 
purifi cation factor by 20%.
[18]
R-phycoerythrin
(Gracilaria Sp.)
Co-Surfactant
Imidazolium-, 
phosphonium-, 
quaternary ammonium-, 
pyridinium, and alkyl 
sulfonate-based families
10% Tergitol 15-S-7 + 
0.3% SAIL (pH7)
R-phycoerythrin purifi cation is independent of the IL-family in study, and the best 
results were obtained with 2 consecutive steps of the [N1,1,12,(C7H7)]Br AMTPS. Higher 
purifi cation performance was achieved with ATPMS with lower micelle diameter, 
suggesting strong interactions between the proteins and the micelles, rather than 
with the micelles size.
[19]
Abbreviations: Abt – Abietate; Ac – Acetate; ADH – Alcohol dehydrogenase; AMTPS – Aqueous Micellar Two-Phase Systems; Asc – Ascorbate; [CF3SO3]
- - trifl uoromethanesulfonate anion; [Ch]+
- Choline cation; [CHES]- - 2-(cyclohexylamino)ethanesulfonic acid anion; [CH3SO3]
- - Methanesulfonate anion; Cl- - Chloride anion; [C2mim][C2SO4] – 1-ethyl-3-methylimidazolium ethylsulfate; 
[C2mim][(C2H5)2PO4] – 1-ethyl-3-methylimidazolium diethylphosphate; [C2mim][HSO4] – 1-ethyl-3-methylimidazolium hydrogen sulfate; [C2mim]Cl – 1-ethyl-3-methylimidazolium chloride; C3C 
– Coumarine-3-carboxylate; [C4mim]
+ - 1-butyl-3-methylimidazolium cation; [C6mim]Cl – 1-hexyl-3-methylimidazolium chloride; [C10mim]Cl – 1-decyl-3-methylimidazolium chloride; [DMP]
- - 
Dimethyl phosphate anion; D-Gal – D-galactouronate; Gen – Gentisate; GFP – Green Fluorescent Protein; Gly - Glycolate; [HEPES]- - 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid 
anion; IA – Indole-3-acetate; IgG – Immunoglobulin G; IgY – Immunoglobulin Y; IL – Ionic Liquid; Lac – Lactate; LB – Lactobacillus brevis; [MES]- - 2-(N-morpholino) ethanesulfonic acid anion; 
(NH4)2SO4 – Ammonium sulfate; [N1,1,12,(C7H7)]Br - benzyldodecyldimethylammonium bromide; Pyr – Pyruvate; Qui – D-(-)-quinate; SAIL – Surface Active Ionic Liquid; TB – Thermophilic bacterium; 
[TES]- - 2-[(2-hydroxy-1,1-[bis(hydroxymethyl)ethyl)amino]ethane sulfonic acid anion; [Tricine]- - N-[tris(hydroxymethyl)methyl]glycine anion; WSpF – Water-soluble protein fraction.
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acetophenone, namely from 0.038 to 1.75 M in the presence of 70% 
(w/w) of IL.15
Based on the need of developing more benign, scalable and cost-
effective techniques for the purification of immunoglobulin G (IgG) 
as a major biopharmaceutical, Mondal et al16 reported the synthesis 
of bio-based ILs formed by the cholinium cation and anions derived 
from natural sources and their application for the creation of ATPS 
with polypropylene glycol with a molecular weight of 400 g.mol-1 
(PPG 400). Among the synthesized ILs – Choline indole-3-acetate 
([Ch][IA]), choline abietate ([Ch][Abt]), choline glycolate ([Ch][Gly]), 
choline pyruvate ([Ch][Pyr]), choline coumarine-3-carboxylate ([Ch]
[C3C]), choline-L-ascorbate ([Ch][Asc]), choline gentisate ([Ch][Gen]), 
choline-D-(-)-quinate ([Ch][Qui]) and choline-D-galactouronate ([Ch]
[D-Gal]) -, ILs with higher octanol-water partition coefficients - [Ch]
[Abt], [Ch][C3C] and [Ch][Gen] were not able to form an ATPS with PPG 
400, although an exception to this pattern was [Ch][IA]. Contrarily to 
other conventional cholinium-based ATPS, namely cholinium acetate, 
cholinium lactate and cholinium chloride, where precipitation of pure 
IgG is observed, ATPS based on [Ch][Gly], [Ch][Pyr], [Ch][Asc], [Ch]
[D-Gal] and [Ch][Qui] allow the complete extraction and recovery of 
IgG in a single-step. From the bio-IL-based ATPS herein evaluated, the 
system composed by [Ch][Asc] appears as the most promising for the 
extraction of IgG from real samples, which is further confirmed by the 
enrichment of 58% on the IgG purity when compared with IgG present 
in rabbit serum.16
Aiming the extraction of immunoglobulin Y (IgY) from egg yolk 
envisaging their application in passive immunization as an alternative 
to IgG produced by small mammals and considering that the stability 
of this biopharmaceutical (among many other proteins) is greatly 
influenced by pH, Freire and co-workers17 synthesized a series of ILs 
with self-buffering characteristics within the physiological pH region 
(6-8) constituted by the cholinium cation and anions derived from 
Good’s buffers (GB-ILs). GB-ILs and PPG 400 were applied in ATPS 
formation and investigated as extraction platforms for IgY from the 
water-soluble proteins fraction of egg yolk. In general, the highest 
extraction efficiencies (above 90% in a single-step) were found for ATPS 
composed of ILs containing anions derived from Tricine and HEPES, 
although the major contaminant β-livetin was not entirely removed. 
Nevertheless, these systems proved to be useful owing to their benign 
character and ability to maintain the integrity of proteins.17
Along with their use as phase-forming components of ATPS, ILs have 
also been applied as adjuvants18 or co-surfactants.19 Santos et al18 
investigated the use of imidazolium-based ILs in polymer-salt systems 
as a way to increase the purification factors of a clinically relevant 
enzyme - L-asparaginase. The authors found that ILs preferentially 
migrate to the polyethylene glycol (PEG) rich-phase while increasing 
the hydrophobicity of this phase, resulting in a decrease of contaminant 
proteins and higher purification factors. Overall, an integrated strategy 
for the purification of periplasmatic L-asparaginase was developed, 
involving: cell permeabilization, a pre-purification step with 
ammonium sulfate precipitation, IL-ATPS as the main purification step, 
and the recovery of the target protein and contaminant proteins by 
ultrafiltration from the respective phases, thereby allowing the reusing 
and recycling of both phases in new cycles of purification.18
Vicente et al19 used surface-active ionic liquids (SAILs) as co-
surfactants for the isolation of R-phycoerythrin from Red 
macroalgae, bioactive fluorescent compounds with a widespread 
use in food, pharmaceutical, biomedical and cosmetic fields. This was 
accomplished using AMTPS based on tergitol 15-S-7 with SAILs as co-
surfactants. Among the different families of SAILs tested, the AMTPS 
based in benzyldodecyldimethylammonium bromide - [N1,1,12,(C7H7)]Br, 
allowed the recovery of R-phycoerythrin without being contaminated 
by R-phycocyanin, where behavior may be due to the different sizes 
of both phycobiliproteins or by specific interactions taking place 
between the micelles formed and the contaminant fluorescent protein. 
Envisaging an increase in the purity of the target protein, the authors 
proposed the use of a two-step process using sequential AMTPS, and 
described a theoretical approach for the polishing of R-phycoerythrin 
and the recycling and reuse of the phase-forming components.19
On the Hunt for More  
Biocompatible ILs
Some well-known toxicological risks displayed by some ILs, both to 
environment and humans, and that may hinder further large-scale 
applications of ILs has driven the scientific community towards the 
development of novel synthetic strategies, thus resulting in “greener” 
and more biocompatible compounds.20 These ILs use both anionic 
and cationic counterparts derived from biocompatible and natural 
sources, such as the cholinium and glycine-betaine analogs as 
cations which are combined with amino acids, natural acids, among 
others.5,20 Based on the rationale that cholinium chloride is a water 
soluble essential nutrient important for cell membrane structure and 
for the synthesis of vitamins,17 the use of cholinium as the cationic 
moiety has emerged as the most effective approach towards the 
development of ILs of a more biocompatible nature.20 This cation has 
been paired with anions derived from plants natural acids,11 amino 
acids,21 or Good’s buffers,17 and successfully applied in the formation 
of ATPS together with salts or polymers foreseeing the extraction of 
proteins. In general, most of these ILs derived from natural sources 
present a non-ecotoxic character towards the bioluminescent 
bacteria Vibrio fischeri,17 and also revealed to be non-cytotoxic to 
human cell lines.22 More recently, ILs based on glycine-betaine, 
which acumulate in a wide variety of plant species in response to 
environmental stress, have also been investigated.20,23 It was found 
that an increase in the alkyl side chain length of ILs analogues of 
glycine-betaine increases their ecotoxic nature, although these ILs 
display a lower ecotoxicity to Vibrio fischeri than those commercially 
available and usually applied for ATPS formation.23
Protein Recovery and Recycling and 
Reusing of ILs
Aiming a decrease in the environmental and economic impact of 
ATPS, while foreseeing the industrial implementation of IL-based ATPS 
«  SEPARATION  AND PURIFICATION »
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processes, the recycling and reusing of ATPS components (including ILs) 
are essential steps to implement.5,19 In general, several methods have 
been investigated to recover hydrophilic ILs, such as back-extraction 
(solvent extraction, supercritical CO2), solid-phase extraction, induced 
phase separation (salting-out, temperature), membrane-based 
processes or magnetic separations.24 However, the general impact of 
these processes in the stability of the target proteins is not entirely 
known since there are few studies addressing the recycling of ILs in 
protein purifi cation IL-based ATPS processes. As shown in Figure 3, 
we highlight three strategies comprising the successful recovery of 
proteins and recycling of ILs. Pereira et al showed that bovine serum 
albumin (BSA) can be successfully recovered from aqueous solutions 
of phosphonium-based ILs by dialysis, and the IL reused at least two 
more times without decreasing their high extraction effi  ciencies for 
BSA (ca. 100%).12 In addition to dialysis, Ramalho et al demonstrated 
that IgG could be recovered from IL-rich phases (cholinium dihydrogen 
phosphate and cholinium lactate) using ultrafi ltration based on the 
application of a cut-off  fi lter of 30 kDa.25
Based on the use of ATPS composed by cholinium-based ILs and PPG 
400, a thermosensitive, non-toxic and biodegradable polymer, Li et 
al26 showed that by increasing the temperature, the polymer can 
be recovered and reused in the next extraction process. A distinct 
approach for the recovery of GFP from the bottom phase of an 
ATPS composed of 42% (w/w) of PPG 1000 and 4.4 % (w/w) of N,N-
dimethylammonium N’,N’-dimethylcarbamate (DIMCARB), Song et 
al27 subjected the IL-rich phase to rotary evaporation (45 °C and 85 
mbar for 1 h). It should be however remarked that this approach is 
possible because a protic IL was used. During the process, DIMCARB 
dissociated into the gaseous dimethylamine and CO2 but as the 
gasses passed through a condenser unit, the re-association occurs 
and the DIMCARB is reformed in the liquid state. Moreover, FT-IR 
and 13C NMR analysis confi rmed the successful recovery of DIMCARB 
from the bottom-phase while the stability of GFP was well preserved 
during distillation.27
Outlook
Boosted by intrinsic favorable characteristics displayed by ATPS 
(biocompatibility, short equilibration times and easiness in scale-
up), coupled to the advantageous properties generally displayed 
by ILs (non-fl ammability, tunable character and good solvent media 
for biomolecules), ATPS comprising ILs have emerged as a powerful 
technique for the purifi cation of proteins. In general, their use as 
phase-forming components allows high extraction effi  ciencies 
by favoring the partition of proteins to the IL-rich phase. On the 
other hand, the use of ILs as adjuvants in low concentrations in 
typical polymer-polymer or polymer-salt ATPS highly enhances the 
selectivity of such systems, thus allowing the recovery of highly 
purifi ed protein fractions. 
As pointed out earlier by McQueen and Lai,28 the benefi ts of ATPS are 
being increasingly recognized by pharmaceutical companies, and 
despite ATPS use identical instrumentation and similar methodologies 
to the already implemented methods, the cost of typical components 
(mainly polymers) in large-scale ATPS is still a challenge for their 
widespread use in industry.28 However, some ILs are already produced 
at the industrial level with relatively low production costs, and as the 
research intensifi cation on the development of more environmentally- 
and human-friendly ILs proceeds it can be expected that in the near 
future ILs derived from natural and renewable sources could be 
obtained at a low cost. 
Overall, due to the demand for low-cost and more sustainable protein 
purifi cation technologies, ATPS comprising ILs should be considered 
as a viable and eff ective alternative feasible of industrial application.
This work was developed within the scope of the project CICECO-
Aveiro Institute of Materials, FCT Ref. UID/CTM/50011/2019, fi nanced 
by national funds through the FCT/MCTES and was fi nancially 
supported by the project “IL2BioPro” - PTDC/BII-BBF/030840/2017- 
funded by FEDER, through COMPETE2020 - Programa Operacional 
Competitividade e Internacionalização (POCI), and by national funds 
(OE), through FCT/MCTES.
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